To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
iTeos Therapeutics racks up $125m
Cambridge, Massachusetts-based iTeos Therapeutics, a developer of cancer immunotherapies, has raised $125 million in Series B2 financing.
